Trastuzumab tallies up in HER2+ breast cancer.

Autor: Pene, Stacey
Zdroj: PharmacoEconomics & Outcomes News. 11/17/2007, Issue 541, p7-7. 1p.
Databáze: Academic Search Ultimate